Hedelix S.A.

Hedelix S.A. is a European‑market herbal preparation that contains a standardized extract of Hedera helix folium (ivy leaf) at a concentration ratio of 2.2 – 2.9 : 1. The extract is obtained using 50 % ethanol (v/v) and propylene glycol as the extracting agents. Delivered in a liquid form, the product is intended as a supportive agent for respiratory and mucosal health, without a specified pharmaceutical strength or dosage, currently.

Hedelix S.A. is commonly used as an adjunctive herbal option for mild respiratory and mucosal conditions.

- Support of occasional cough associated with upper respiratory tract irritation. - Mild soothing of inflamed or sore throat mucosa. - Adjunctive care for bronchial discomfort in non‑severe asthma or bronchitis. - Complementary use during early stages of common cold to ease throat irritation. - Support of normal mucus clearance when combined with conventional therapy. - Temporary relief of throat dryness caused by environmental irritants. - Potential aid in reducing throat tickle that triggers cough reflex.

Reported side effects of Hedelix S.A. are generally mild and related to the herbal extract or the solvent system.

Common: - Mild gastrointestinal discomfort such as nausea or stomach upset. - Transient taste alteration or a slight after‑taste from ethanol. - Mild skin irritation at the site of contact. - Occasional mild headache. - Mild dizziness or light‑headedness, especially after rapid ingestion. - Temporary increase in salivation. - Mild fatigue lasting a few hours after dose.

Serious: - Allergic reactions ranging from urticaria to angioedema. - Anaphylactic shock in individuals with known ivy allergy. - Severe bronchospasm in patients with hyper‑reactive airways. - Liver enzyme elevation observed in rare prolonged use. - Severe allergic dermatitis with extensive rash.

When considering Hedelix S.A., several precautionary measures help ensure safe use, especially for vulnerable populations.

- Do not use if you have a documented allergy to ivy (Hedera helix) or any component of the formulation. - Pregnant or breastfeeding individuals should consult a healthcare professional before use. - Keep the product out of reach of children; accidental ingestion may cause adverse effects. - Avoid use in severe asthma or chronic obstructive pulmonary disease without medical supervision. - Limit concurrent use with other herbal cough remedies to prevent excessive exposure to ivy extract.

Hedelix S.A. may interact with certain medications or other herbal products; awareness of these interactions can help prevent adverse outcomes.

Avoid: - Concurrent use with other ivy‑containing supplements or cough syrups, which could increase the risk of allergic reactions. - Combining with strong CYP450 inhibitors is not recommended, as it may alter the metabolism of co‑administered drugs.

Use with caution: - Alcohol consumption may enhance the sedative effect of ethanol in the formulation; limit intake. - Anticoagulant or antiplatelet therapy should be monitored, as ivy extract may affect platelet function. - Patients on bronchodilators for asthma should be observed for potential bronchospasm when adding the product.